Hyderabad based HRV Pharma, India’s ‘first virtual pharmaceutical company’, started off as a B2B match maker between Indian ...

CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of ...

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

Teva Pharmaceutical Industries Limited TEVA announced that it has submitted a new drug application (NDA) to the FDA seeking approval for olanzapine, a long-acting subcutaneous injectable (LAI) for ...

Novo Nordisk NOVO.B9.24%increase; green up pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

FILE: Mifepristone tablets are seen in a Planned Parenthood clinic, July 18, 2024, in Ames, Iowa. TALLAHASSEE — Florida and Texas have filed a lawsuit challenging more than two decades of ...

Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US Food and Drug Administration (FDA) for its breast cancer risk prediction model, Lunit INSIGHT Risk.

Novo Nordisk filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity. CagriSema combines the main ingredient in Wegovy with ...

Americans are increasingly treating ChatGPT as a stand-in for their personal physician, with 40 million saying they use it to ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that ...